The molecular genetics of pathological gambling

CNS Spectrums

Volumn 3, Issue 6, 1998, Pages 20-37

  Comings, David E ^a  

^a Medical Center in Duarte   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR;

ADDICTION; BEHAVIOR DISORDER; COMORBIDITY; DEPRESSION; DOPAMINERGIC SYSTEM; ENVIRONMENTAL FACTOR; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GILLES DE LA TOURETTE SYNDROME; HUMAN; MOLECULAR GENETICS; MULTIFACTORIAL INHERITANCE; PATHOLOGICAL GAMBLING; PEDIGREE ANALYSIS; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; REWARD;

EID: 0032465456     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S109285290000599X     Document Type: Review

References (81)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Volberg RA. The prevalence and demographics of pathological gamblers: implications for public health. Am J Public Health. 1994;84:237-241.
3. Beckham J. Gamble: weary bettors pay the ultimate toll for habit. Los Angeles Times. June 22,1997; A14-A15.
4. Rosenthal RJ. Pathological gambling. Psychiatric Annals. 1992;22:72-78.
5. Lesieur HR, Blume SB, Zoppa RM. Alcoholism, drug abuse and gambling. Alcohol Clin Exp Res. 1984;10:33-38.
6. Levinson PK, Gerstein DR, Maloff DR. Commonalities in Substance Abuse and Habitual Behaviors. Lexington, Ky: Lexington Books; 1983.
7. Ramirez LF, McCormick RA, Russo AM, et al. Patterns of substance abuse in pathological gamblers undergoing treatment. Addict Behav. 1984;8:425-428.
8. Lesieur HR, Heineman M. Pathological gambling among youthful multiple substance abusers in a therapeutic community. Br J Addict. 1988;83:765-771.
9. Carlton PL, Manowitz P, McBride H, Nora R, Swartzburg M, Goldstein L. Attention deficit disorder and pathological gambling. J Clin Psychiatry. 1987;48:487-488.
10. Rugle L. Neuropsychological Assessment of Attention Deficit Disorder in Pathological Gamblers [dissertation]. Kent, Ohio: Kent State University; 1990.
11. Rugle L, Melamed L. Neuropsychological assessment of attention problems in pathological gamblers. J Nerv Ment Dis. 1993;181:107-112.
12. Carlton PL, Goldstein L. Physiological determinants of pathological gambling. In: Galski T, ed. Handbook on Pathological Gambling. Springfield, Ill: Charles C. Thomas Publisher; 1987.
13. Blaszcynski A, McConaghy N, Frankova A. Crime, antisocial personality and pathological gambling. Gambling Behav. 1989;5:137-152.
14. Rosenthal RJ. The pathological gambler's system of self-deception. Gambling Behav. 1986;2:108-120.
15. Glenn A. The narcissistic personality as it relates to pathological gamblers. Presented at: 7th International Conference on Gambling and Risktaking; 1987; Reno, Nev.
16. Russo AM. The Relationship Between Pathological Gambling and Narcissism [master's thesis]. Athens, Ohio: Ohio University; 1987.
17. McCormick RA, Russo AM, Ramirez LF, Taber JI. Affective disorders among pathological gamblers seeking treatment. Am J Psychiatry. 1984;141:215-218.
18. Linden RD, Pope HG, Jonas SM. Pathological gambling and major affective disorder: preliminary findings. J Clin Psychiatry: 1986;47:201-203.
19. Comings DE. Polygenetic inheritance of psychiatric disorders. In: Blum K, Noble EP, Sparks RS, Sheridan PJ, eds. Handbook of Psychiatric Genetics. Boca Raton, Fla: CRC Press; 1996:235.
20. Comings DE. Polygenic inheritance and micro/minisatellites. Mol Psychiatry. 1998;3:21-31.
21. Comings DE. Why different rules are required for investigating polygenic inheritance: lessons from studies of the DRD2 gene in addictive behaviors. Alcohol Clin Exp Res. In press.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, rev. Washington, DC: American Psychiatric Association; 1987.
23. Comings DE. Tourette Syndrome and Human Behavior. Duarte, Calif: Hope Press; 1990.
24. Hudson JI, Pope HG Jr. Affective spectrum disorder: does antidepressant response indentify a family of disorders with a common pathophysiology? Am J Psychiatry. 1990;147:552-564.
25. McElroy SL, Hudson JI, Pope HG Jr, Keck PE, Aizley HG. The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationship to other psychiatric disorders. Am J Psychiatry. 1992;149:318-327.
26. Comings DE, Comings BG. Comorbid behavioral disorders. In: Kurlan R, ed. Handbook of Tourette's Syndrome and Related Tic and Behavioral Disorders. New York, NY: Marcel Dekker; 1993:111.
27. Sacks O. Awakenings. 4th ed. New York, NY: EP Dutton; 1983.
28. 2 receptor gene in alcoholism. JAMA. 1990;263:2055-2059.
29. 2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet. 1989;45:778-785.
30. 2 dopamine receptor gene: A review of association studies in alcoholism. Behav Genet. 1993;23:119-129.
31. 2 receptor gene variants: Association and linkage studies in impulsive-addictive-compulsive behavior. Pharmacogenetics. 1995;5:121-141.
32. 2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA. 1991;266:1793-1800.
33. Pakstis AJ, Heutink P, Pauls DL, et al. Progress in the search for genetic linkage with Tourette syndrome: An exclusion map covering more than 50% of the autosomal genome. Am J Hum Genet. 1991;48(2):281-291.
34. Comings DE, Wu H, Chin C, Ring RH, Dietz G, Muhleman D. Polygenic inheritance of Tourette's syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: The additive and subtractive effect of the three dopaminergic genes -DRD2, D beta H and DAT1. Am J Med Genet. 1996;67:261-288.
35. Comings DE. The role of genetic factors in conduct disorder based on studies of Tourette's syndrome and ADHD probands and their relatives. J Dev Behav Pediatr. 1995;16:142-157.
36. Comings DE. Search for the Tourette's Syndrome and Human Behavior Genes. Duarte, Calif: Hope Press; 1996.
37. Blum K, Cull JG, Braverman ER, Comings DE. Reward deficiency syndrome. Am Scientist. 1996;84:132-145.
38. 2 receptor gene in pathological gambling. Pharmacogenetics. 1996;6:223-231.
39. 2-like dopamine receptor agonists. Science. 1996;271:1586-1589.
40. 1 receptor gene in addictive behaviors. Mol Psychiatry. 1997;2:44-56.
41. 1 receptor gene (DRD1). Hum Mol Genet. 1994;3:209.
42. 3 receptor gene. J Med Genet. 1992;29:858-860.
43. 3 receptor gene in schizophrenia. Mol Psychiatry. 1996;1:125-132.
44. 3 receptor gene. Lancet. 1993:311:906.
45. 3 receptor gene - reply [editorial]. Lancet. 1993;311:1483-1484.
46. 4 receptor variants in human population. Nature. 1992;358:149-152.
47. 4 receptor gene association with normal personality traits. Psychiatr Genet. 1995;5:S36.
48. 4 receptor polymorphism associated with personality variation in normals. Psychiatr Genet. 1995;5:S36.
49. 4 receptor (DRD4) 16 amino acid repeat polymorphisms and novelty seeking. Mol Psychiatry. 1996;1:388-391.
50. 4 receptor locus with Tourette's syndrome by TDT. Am J Hum Genet. 1996;59:611-652.
51. 4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry. 1996;1:121-124.
52. 4 receptor (DRD4) exon III seven repeat allele in opioid dependent subjects. Mol Psychiatry. 1997;2:251-251.
53. Banki CM, Arato M, Papp Z, Kurz XI. Biochemical markers in suicidal patients. Investigations with cerebrospinal fluid amine metabolites and neuroendrocrine tests. J Affect Disord. 1981;6:341-350.
54. Branchey L, Branchey M, Shaw S, Lieber CS. Depression, suicide, and aggression in alcoholics and their relationship to plasma amino acids. Psychiatry Res. 1984;12:219-226.
55. Brown GL, Ebert MF, Goyer PH, et al. Aggression, suicide and serotonin relationships to CSF amine metabolism. Am J Psychiatry. 1982;139:741-746.
56. Brown S-L, van Praag HM. The Role of Serotonin in Psychiatric Disorders. New York, NY: Brunner/Mazel; 1990.
57. Comings DE, Muhleman D, Dietz G, Sherman M, Forest G. Sequence of human tryptophan 2,3-dioxygenase: presence of a glucocorticoid response-like element composed of a GTT repeat and an intronic CCCCT repeat. Genomics. 1995;29:390-396.
58. Comings DE, Muhleman D, Gade R, et al. Exon and intron mutations in the human tryptophan 2,3-dioxygenase gene and their potential association with Tourette's syndrome, substance abuse and other psychiatric disorders. Pharmacogenetics. 1996;6:307-318.
59. Wiberg A, Gottfries CG, Oreland L. Low platelet monoamine oxidase activity in human alcoholics. Med Biol. 1977;55:181-186.
60. Gottfries CG, Oreland L, Wiberg A, Winblad B. Lowered monoamine oxidase activity in brains from alcoholic suicides. J Neurochem. 1975;25:667-673.
61. Devor EJ, Cloninger CR, Hoffman PL, Tabakoff B. Association of monoamine oxidase (MAO) activity with alcoholism and alcoholic subtypes. Am J Med Genet. 1991;48:209-213.
62. Vonknorring AL, Hallmann J, Vonknorring L, Oreland L. Platelet monoamine oxidase activity in type-1 and type-2 alcoholism. Alcohol Alcohol. 1991;26:409-416.
63. Sherif F, Marcusson J, Oreland L. Brain gamma-aminobutyrate transaminase and monoamine oxidase activities in suicide victims. Eur Arch Psychiatry Clin Neurosci. 1991;241:139-141.
64. Pandey GN, Sharma RP, Janicak PG, Davis JM. Monamine oxidase and cortisol response in depression and schizophrenia. Psychiatry Res. 1992;44:1-8.
65. Pandey GN, Dorus E, Shaughnessy R, Gaviria M, Val E, Davis JM. Reduced platelet MAO activity and vulnerability to psychiatric disorders. Psychiatry Res. 1980;2:315-321.
66. Buchsbaum MS, Coursey RD, Murphy DL. The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity. Science. 1976;191:339-341.
67. Buchsbaum MS, Haier RJ, Murphy DL. Suicide attempts, platelet monamine oxidase and the average evoked response. Acta Psychiatr Scand. 1977;56:69-79.
68. Meltzer HY, Arora RC. Platelet markers of suicidalily. Ann NY Acad Sci. 1986;487:271-280.
69. Skekim WO, Davis LG, Bylund DB, Brunngraber E, Fikes L, Lanham J. Platelet MAO in children with attention deficit disorder and hyperactivity: A pilot study. Am J Psychiatry. 1982;139:936-938.
70. Schooler C, Zahn TP, Murphy DL, Buchsbaum MS. Psychological correlates of monoamine oxidase acivity in normals. J Nerv Ment Dis. 1978;166:177-186.
71. Shekim WO, Bylund DB, Frankel F, et al. Platelet MAO activity and personality variations in normals. Psychiatry Res. 1989;27:81-88.
72. Vonknorring L, Oreland L, Winblad B. Pesonality traits related to monoamine oxidase activity in platelets. Psychiatry Res. 1984;12:11-26.
73. Mann JJ, Stanley M. Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls. Acta Psychiatr Scand. 1984;69:135-139.
74. Propping P, Rey ER, Friedl W, Beckmann H. Platelet monoamine oxidase in healthy subjects: The "biochemical high-risk paradigm" revisited. Arch Psychiatr Nervenkr. 1981;230:209-219.
75. Tabakoff B, Hoffman PL, Lee JM, Saito T, Willard B, Leon-Jones FD. Differences in platelet enzyme activity between alcoholics and nonalcoholics. N Engl J Med. 1988;318:134-139.
76. Blanco C, Orensanz-Muñoz L, Blanco-Kerez C, Saizruiz J. Pathological gambling and platelet MAO activity: A psychobiological study. Am J Psychiatry. 1966;153:119-121.
77. DiChiara G, Imperato A. Drugs abused by humans preferentially increase synoptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA. 1988;85:5274-5278.
78. Routtenberg A. The reward system of the brain. Sci Am. 1978;239:154-165.
79. Wise RA, Rompre PP. Brain dopamine and reward. Ann Rev Psychol. 1989;40:191-225.
80. Kuhar MJ, Ritz MC, Boja JW. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 1991;14:299-302.
81. Koob GF. Drug of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci. 1992;13:177-184.